Primary Immunodeficiency Diseases Consortium Conference

说明（由申请人提供）：本资助申请为出席2009年原发性免疫缺陷疾病联盟会议的演讲者提供旅费资助。这笔赠款将用于支持参与者的旅行和协助项目发展。将向制药和生物技术公司征求额外资金。该项目是与USIDNET共同组织的，计划在临床免疫学学会联合会（FOCIS）年会之前举行。该计划将在临床免疫学学会（CIS）、FOCIS、美国过敏、哮喘和免疫学学会（AAAAI）、欧洲免疫缺陷学会（ESID）和USIDNET的网站上发布广告。除了在他们的网站上发布这些信息外，他们还将向他们的会员发出通知，宣传联盟。这项活动的目的是要接触到一个国际目标受众，包括在培训中的研究员、初级教员和该领域的著名专家。该联盟计划汇集该领域的专家，讨论最近的更新以及与我们对各种原发性免疫缺陷影响的科学过程的理解相关的材料。通过讲座和研讨会期间的网络交流，临床医生和研究人员将对原发性免疫缺陷有一个更好的认识。这些材料将主要以讲座形式提供，但也会有一个海报会议和安排的休息时间，以便与最先进的讲师建立联系，指导和一对一的时间。本次会议的目标是继续推进对这些复杂疾病的诊断、分子缺陷、并发症和治疗的理解；在这一学术医学领域发展新科学家的事业；提高对临床免疫学的认识及其在科学发现和临床应用中的重要性；并促进不同医疗中心和国家的研究人员之间的未来合作，以及新研究人员和该领域经验丰富的医生科学家之间的合作。原发性免疫缺陷疾病联盟会议的使命是汇集来自世界各地的专家，讨论在任何一个机构通常不常见的疾病的诊断，发病机制和管理。重点将放在对原发性免疫缺陷的理解方面的最新进展。拟议的原发性免疫缺陷疾病联盟会议将汇集该领域的专家，讨论最近的更新以及与我们对各种原发性免疫缺陷影响的科学过程的理解相关的材料。这次研讨会将提高医生和基础研究人员在该领域的知识，但最终将导致改善患者护理。

DESCRIPTION (provided by applicant): This grant requests support for travel grants to be provided to presenters for attending the 2009 Primary Immunodeficiency Diseases Consortium Conference. This grant will provide funding to support travel for the participants and assist with program development. Additional funding will be solicited from pharmaceutical and biotechnology companies. This program, which is co-organized with the USIDNET, is scheduled to take place just prior to the Federation of Clinical Immunology Societies (FOCIS) Annual Meeting. The program will be advertised on websites from the Clinical Immunology Society (CIS), FOCIS, the American Academy of Allergy, Asthma & Immunology (AAAAI), the European Society of Immunodeficiency (ESID), and the USIDNET. In addition to posting this information on their web sites, they will also send out notices to their membership advertising the Consortium. This activity is intended to reach an international target audience consisting of fellows-in-training, junior faculty, as well as noted experts in the field. This Consortium plans to bring together experts in the field to discuss recent updates as well as material related to our understanding of the scientific processes affected in various primary immunodeficiencies. Both by lecture and networking during the symposium, clinicians and researchers will come away with an improved knowledge of primary immunodeficiencies. The material will be delivered primarily in lecture format, but there will also be a poster session and scheduled breaks to allow networking, mentoring, and one-on-one time with the state-of-the art lecturers. The objectives for this conference are to continue to advance understanding of the diagnosis, molecular defects, complications, and treatment of these complex diseases; to develop the careers of new scientists in this area of academic medicine; to enhance awareness of clinical immunology and its importance in scientific discoveries and clinical applications; and to stimulate future collaborations between investigators in different medical centers and countries, and between new investigators and experienced physician-scientists in the field. The mission of the Primary Immunodeficiency Diseases Consortium Conference is to bring together experts from around the world to discuss diagnosis, pathogenesis, and management of diseases which are often uncommon at any one institution. The emphasis will be on recent advances in the understanding of primary immunodeficiencies. The proposed Primary Immunodeficiency Diseases Consortium Conference will bring together experts in the field to discuss recent updates as well as material related to our understanding of the scientific processes affected in various primary immunodeficiencies. This symposium will enhance knowledge of physicians and basic researchers in the field but will ultimately lead to improved patient care.